Delafloxacin: design, development and potential place in therapy

Francisco Javier Candel, Marina Peñuelas Department of Clinical Microbiology and Infectious Diseases, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Universidad Complutense, Madrid, Spain Abstract: Delafloxacin (DLX) is a new...

Full description

Bibliographic Details
Main Authors: Candel FJ, Peñuelas M
Format: Article
Language:English
Published: Dove Medical Press 2017-03-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/delafloxacin-design-development-and-potential-place-in-therapy-peer-reviewed-article-DDDT